# Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis

> **NCT05110937** · — · RECRUITING · sponsor: **University of Florida** · enrollment: 450 (estimated)

## Conditions studied

- Sepsis
- Trauma Injury

## Interventions

- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT05110937
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-04
- **Primary completion:** 2026-07
- **Final completion:** 2027-04
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110937, "Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05110937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*